Back to Agenda
Session 10: Endpoints in Clinical Development
Session Chair(s)
Yazhong Deng, MBA
CEO and Founder
Beijing Trust Medical Consulting Co. Ltd, China
Jie Chen, PhD
Director, Global Biostatistics
Merck Serono (Beijing) Pharmaceutical R&D Co. Ltd., China
Speaker(s)
FDA PRO Guidance and the Validation of a PRO
Shanmei Liao
Pfizer(China) Research and Development Co., Ltd., China
senior biostatistician
Statistical aspects of PRO data analysis
Ekkehard Glimm
Novartis, Switzerland
Biometrical Fellow
The application of PRO in TCM
BaoYan Liu
China Academy of Chinese Medical Sciences, China
Have an account?